Permira to acquire Spanish pharma company Neuraxpharm from Apax Partners
Permira, a UK-based private equity firm, said that a company backed by its funds has agreed to acquire Neuraxpharm, a specialty pharma company focused on the treatment of the central nervous system (CNS) from funds advised by Apax Partners. Financial details of the deal were not revealed. Based in Spain and Germany, Neuraxpharm is engaged […]